SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak quarterly results, sharply reduced full-year outlook and suspension of its dividend have intensified selling and concerns about its finances; the company cited recession-level appliance demand and weaker consumer confidence. Traders debate whether macroeconomic pressures are chiefly to blame or whether years of debt and management problems are driving the decline, with some viewing the selloff as a buying opportunity and others fearing further distress.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is drawing attention after a cybersecurity-sector rally tied to headlines about AI-discovered vulnerabilities and a critical PHP flaw, which traders say could heighten demand for security products. Some see the move as evidence of strong sector momentum, while others question whether the rally is justified given CRWDs lofty valuation.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARKK is drawing attention for a tentative rebound and attempts to break out of a prolonged, volatile base, with bullish traders pointing to improving momentum and renewed interest in growth stocks. Others remain skeptical, citing the funds past underperformance and Cathie Woods portfolio decisions.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

ESMO updates on RASONQUE and RAS-targeted combinations are driving discussion, including reported survival benefits across patient subgroups and promising pancreatic-cancer data from Tangos combination with daraxonrasib. Traders are debating whether delays among rival programs could extend Revolution Medicines lead, while weighing the competitive landscape and how the clinical findings translate into durable benefit.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JDs earnings have sparked debate after shares sold off despite improving profitability and cash flow: bulls view the reaction as excessive and cite the companys cash, buybacks and low valuation, while bears focus on declining revenue and weak Chinese consumer demand. The discussion also reflects persistent caution toward Chinese equities and uncertainty over whether JD can turn better margins into renewed growth.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Toshibas plans to expand hard-drive capacity have pressured Seagate on fears that added supply could erode HDD pricing power, with reports of a SeagateToshiba contest for TDKs magnetic-head business adding uncertainty. Traders are split between seeing the selloff as an overreaction given strong AI data-center storage demand and a long supply ramp, and viewing increased competition as a threat to the scarcity-driven rally.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

A reopened Space Force SCAR procurement process and related securities-suit allegations over whether AeroVironment disclosed competition risks have weighed on shares; the claims remain allegations. Traders are debating whether the sharp selloff has created a base or could extend, while bulls point to defense contracts, backlog and counter-drone demand as support for a recovery case.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing attention amid a volatile crypto-market pullback, with traders focused on whether it can hold technical support after selloffs and leveraged-position liquidations. Sentiment is split between calls for further downside and dip buyers anticipating a reversal or short squeeze.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Attention centers on reports that Papa Johns largest U.S. franchisee has joined Irth Capitals effort to take the company private. No deal is confirmed, and traders are debating whether negotiations will advance or the board will reject or delay a sale, against a backdrop of weak sales and a sharp share-price decline.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

VOO is drawing attention amid a broader market pullback, with traders debating whether weakness tied to inflation, elevated yields and geopolitical oil risks could deepen or prove temporary. Bearish crash warnings contrast with dip-buying and long-term investors who view index declines as accumulation opportunities.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MLTX Stock Under Pressure As Investors Await Psoriatic Arthritis Trial Data  

Equity

MoonLake has consistently guided for a “mid-2026” primary endpoint readout from IZAR-1, its late-stage trial for sonelokimab in certain patients with active psoriatic arthritis. 


MLTX Stock Garners Retail Attention On Buyout Speculation, Positive Skin Condition Trial Data

A Stocktwits user highlighted optimism for a buyout for MoonLake, highlighting other recent mergers and acquisitions in the pharma industry, such as Biogen’s buyout of Apellis.


MLTX Stock Gains As Retail Eyes Buyout From Big Pharma, Upcoming Investor Day Event

Some Stocktwits users voiced optimism for the inflammation-drug maker getting acquired by pharma giant Merck. 

MLTX Stock Extends Rally As FDA Feedback Spurs Bullish Brokerage Action – Retail Speculates On Potential M&A Conversations

BTIG upgraded MoonLake Immunotherapeutics to ‘Buy’ from ‘Neutral’ after the FDA said the company could show the effectiveness of Sonelokimab without additional HS trials.

Why Did MLTX Stock Jump 45% In Pre-Market Today?

The company said it received positive regulatory feedback from the U.S. FDA following a Type B meeting regarding a drug used to treat hidradenitis suppurativa, a chronic inflammatory skin disorder.

iShares Trust - iShares ESG Aware MSCI USA Small-Cap ETF

Neutral Sentiment

<ul class="summary-bullets"><li>During its Investor Day on June 22, management stated that the company’s largest trial to date “will read in about a month’s time.”</li><li>MoonLkae has two additional catalysts slated for the remainder of the year.&nbsp;</li><li>The company plans to submit an application to the U.S. Food and Drug Administration seeking approval for sonelokimab in hidradenitis suppurativa at the end of September 2026.</li></ul>Shares of MoonLake Immunotherapeutics (MLTX) traded 5% lower on Monday as traders await the results of a key clinical trial of the company’s sonelokimab in certain patients with active psoriatic arthritis (PsA).MoonLake has consistently guided for a “mid-2026” primary endpoint readout from IZAR-1, its late-stage trial for sonelokimab in patients with active psoriatic arthritis (PsA) who have not been treated with a specific class of therapy called biologics. More specifically, during its Investor Day on June 22, management stated that the company’s largest trial to date “will read in about a month’s time.”That commentary pointed to a late-July or early-August 2026 announcement window. As of Monday, the data has not yet been released. Investors continue to debate whether the results will arrive as a standalone press release or potentially be timed alongside the company’s upcoming Q2 2026 financial results.IZAR-1 is a large late-stage trial testing MoonLake’s drug sonelokimab in about 960 adults with psoriatic arthritis. Psoriatic arthritis (PsA) is a long-term condition that affects some people who have (or have had) psoriasis — the skin disease that produces red, scaly patches. In PsA, the immune system mistakenly attacks the joints and the places where tendons and ligaments attach to bone, leading to pain, stiffness, and swelling.Patients in the IZAR-1 trial are randomly given either the real drug or a placebo, and neither they nor their doctors know which one they received. The main goal is to prove the drug works better than the placebo at meaningfully improving joint symptoms after 16 weeks. The trial also checks other benefits, such as clearer skin, overall better disease control, and how patients feel in daily life.<h2 class="st-heading-2">Other Near-Term Catalysts For MLTX</h2>Beyond IZAR-1, MoonLake’s pipeline and regulatory calendar remain busy through the rest of 2026.The company plans to submit an application to the U.S. Food and Drug Administration seeking approval for sonelokimab in hidradenitis suppurativa, a chronic, painful inflammatory skin disease, at the end of September 2026. Acceptance and a potential Priority Review decision are expected by the end of November 2026, with a possible U.S. launch targeted for the second half of 2027 if approved.Another late-stage trial in PsA patients who did not respond well to an older class of drugs is expected to report its main results in the second half of 2026.MoonLake raised roughly $200 million in a public offering in late June, strengthening its cash position to fund these steps.<h2 class="st-heading-2">How Did MLTX Retail Traders React?</h2>On Stocktwits, retail sentiment around MLTX stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.A Stocktwits user voiced optimism for trial success with IZAR-1, citing strong mid-stage trial outcomes.<stembedurl>https://www.stocktwits.com/Doxtator/message/660675293</stembedurl>Another expects the company to announce the trial outcome by mid-August, urging others to “hold.”<stembedurl>https://www.stocktwits.com/TheSuper/message/660698199</stembedurl><a href="https://stocktwits.com/symbol/MLTX">MLTX stock</a> has gained nearly 33% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/northrop-grumman-to-boost-missile-component-production-for-arsenal-of-freedom-retail-views-steady-execution-to-be-key-for-growth/cZoTS9dRJ32">Northrop Grumman To Boost Missile Component Production For ‘Arsenal of Freedom’ – Retail Views Steady Execution To Be Key For Growth</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a MoonLake Immunotherapeutics company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

During its Investor Day on June 22, management stated that the company’s largest trial to date “will read in about a month’s time.”MoonLkae has two additional catalysts slated for the remainder of the year. The company plans to submit an application to th

iShares ESG Aware MSCI USA Small-Cap ETF

MoonLake Immunotherapeutics

Vanguard Health Care ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

ESML iShares ESG Aware MSCI USA Small-Cap ETF

Fundamentals

Latest ESML News